Presentations

11:00

Clinical, histological and tissue proteomic features of decline after idiopathic acute lung allograft dysfunction

Pamela Karas (AU)

Bio Abstract

11:10

Longitudinal immunophenotyping identifies early postoperative CD8-positive PD-1-positive T cells as an independent predictor of 1-year mortality after lung transplantation

Tianyi Yang (CN)

Bio Abstract

11:17

Predicting acute kidney injury following lung transplantation: development and internal validation of perioperative prediction models

Shogo Trevena (AU)

Bio Abstract

11:24

Family Experiences and Ethical Acceptability of Lung uDCD Authorization in an Opt-In System

Jingzhi Xu (US)

Bio Abstract

11:31

Donor Lung Microbiome and Metabolic Signatures Predict Primary Graft Dysfunction After Lung Transplantation

Guodong Wu (CN)

Bio Abstract

11:36

Randomized controlled trial comparing immediate versus extended-release tacrolimus in lung transplant recipients: the REVOLUTION trial

Juul Daamen (NL)

Bio Abstract

11:41

Excellent Long-Term Outcomes in Paediatric Lung Transplantation Within a Centralised, Co-located Adult Program

Miranda Paraskeva (AU)

Bio Abstract

11:46

Lung Allograft Injury Improves After Gastroesophageal Reflux Surgery According To Donor-derived Cell-free DNA

Cesar Escrig (CH)

Bio Abstract